For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body's natural clotting response.
Scope of the Report:
This report focuses on the Vascular Closure Devices (VCDS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The North America regions suggest an array of opportunities for growth and are likely to be getting into the eyes of new investors in the vascular closure market. Growth is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The Vascular closure market is expected to grow steadily in the forecast period. The factors driving the growth of this market are increasing catheterization related procedures (PCI), preference for minimally-invasive solutions & rise in vascular procedures. Ease in usage and quick hemostatic properties of VCDs and increased utilization of transradial arterial access are some of the opportunities that are propelling the growth of the market.
High price of products, complications associated with VCD, less adoption of novel technologies in emerging countries are hampering the market of vascular closure. Reduced reimbursement, usage of animal related sources and lower revenue potential of VCD are threats for the market growth.
The worldwide market for Vascular Closure Devices (VCDS) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Abbott Laboratories
- St. Jude Medical
- Cardinal Health
- Morrris Innovative
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Angiography Surgery
- Interventional Procedures
There are 15 Chapters to deeply display the global Vascular Closure Devices (VCDS) market.
Chapter 1, to describe Vascular Closure Devices (VCDS) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Vascular Closure Devices (VCDS), with sales, revenue, and price of Vascular Closure Devices (VCDS), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Vascular Closure Devices (VCDS), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Vascular Closure Devices (VCDS) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Vascular Closure Devices (VCDS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source